GMED
Price
$87.51
Change
+$0.45 (+0.52%)
Updated
Feb 5, 02:59 PM (EDT)
Capitalization
11.65B
14 days until earnings call
Intraday BUY SELL Signals
LIVN
Price
$65.89
Change
+$0.46 (+0.70%)
Updated
Feb 5, 03:19 PM (EDT)
Capitalization
3.57B
20 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GMED vs LIVN

Header iconGMED vs LIVN Comparison
Open Charts GMED vs LIVNBanner chart's image
Globus Medical
Price$87.51
Change+$0.45 (+0.52%)
Volume$700
Capitalization11.65B
LivaNova
Price$65.89
Change+$0.46 (+0.70%)
Volume$200
Capitalization3.57B
GMED vs LIVN Comparison Chart in %
GMED
Daily Signal:
Gain/Loss:
LIVN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GMED vs. LIVN commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMED is a Buy and LIVN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (GMED: $87.06 vs. LIVN: $65.43)
Brand notoriety: GMED and LIVN are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: GMED: 119% vs. LIVN: 131%
Market capitalization -- GMED: $11.65B vs. LIVN: $3.57B
GMED [@Medical/Nursing Services] is valued at $11.65B. LIVN’s [@Medical/Nursing Services] market capitalization is $3.57B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $188.15B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GMED’s FA Score shows that 0 FA rating(s) are green whileLIVN’s FA Score has 0 green FA rating(s).

  • GMED’s FA Score: 0 green, 5 red.
  • LIVN’s FA Score: 0 green, 5 red.
According to our system of comparison, both GMED and LIVN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GMED’s TA Score shows that 4 TA indicator(s) are bullish while LIVN’s TA Score has 3 bullish TA indicator(s).

  • GMED’s TA Score: 4 bullish, 5 bearish.
  • LIVN’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, GMED is a better buy in the short-term than LIVN.

Price Growth

GMED (@Medical/Nursing Services) experienced а -5.19% price change this week, while LIVN (@Medical/Nursing Services) price change was +2.38% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +2.33%. For the same industry, the average monthly price growth was -3.36%, and the average quarterly price growth was +12.28%.

Reported Earning Dates

GMED is expected to report earnings on Feb 19, 2026.

LIVN is expected to report earnings on Feb 25, 2026.

Industries' Descriptions

@Medical/Nursing Services (+2.33% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GMED($11.7B) has a higher market cap than LIVN($3.57B). LIVN has higher P/E ratio than GMED: LIVN (30.31) vs GMED (28.17). LIVN YTD gains are higher at: 6.338 vs. GMED (-0.286). GMED has higher annual earnings (EBITDA): 710M vs. LIVN (-80.23M). LIVN has more cash in the bank: 646M vs. GMED (391M). GMED has less debt than LIVN: GMED (119M) vs LIVN (487M). GMED has higher revenues than LIVN: GMED (2.77B) vs LIVN (1.35B).
GMEDLIVNGMED / LIVN
Capitalization11.7B3.57B327%
EBITDA710M-80.23M-885%
Gain YTD-0.2866.338-5%
P/E Ratio28.1730.3193%
Revenue2.77B1.35B205%
Total Cash391M646M61%
Total Debt119M487M24%
FUNDAMENTALS RATINGS
GMED vs LIVN: Fundamental Ratings
GMED
LIVN
OUTLOOK RATING
1..100
6411
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
67
Overvalued
PROFIT vs RISK RATING
1..100
6998
SMR RATING
1..100
7095
PRICE GROWTH RATING
1..100
4342
P/E GROWTH RATING
1..100
9999
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LIVN's Valuation (67) in the Medical Specialties industry is in the same range as GMED (74). This means that LIVN’s stock grew similarly to GMED’s over the last 12 months.

GMED's Profit vs Risk Rating (69) in the Medical Specialties industry is in the same range as LIVN (98). This means that GMED’s stock grew similarly to LIVN’s over the last 12 months.

GMED's SMR Rating (70) in the Medical Specialties industry is in the same range as LIVN (95). This means that GMED’s stock grew similarly to LIVN’s over the last 12 months.

LIVN's Price Growth Rating (42) in the Medical Specialties industry is in the same range as GMED (43). This means that LIVN’s stock grew similarly to GMED’s over the last 12 months.

LIVN's P/E Growth Rating (99) in the Medical Specialties industry is in the same range as GMED (99). This means that LIVN’s stock grew similarly to GMED’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GMEDLIVN
RSI
ODDS (%)
Bearish Trend 2 days ago
54%
Bearish Trend 2 days ago
68%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
64%
Bearish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
60%
Bullish Trend 2 days ago
70%
MACD
ODDS (%)
Bearish Trend 2 days ago
61%
Bullish Trend 2 days ago
64%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
57%
Bullish Trend 2 days ago
67%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
58%
Bullish Trend 2 days ago
62%
Advances
ODDS (%)
Bullish Trend 15 days ago
65%
Bullish Trend 4 days ago
68%
Declines
ODDS (%)
Bearish Trend 2 days ago
57%
Bearish Trend 2 days ago
75%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
58%
Bearish Trend 2 days ago
78%
Aroon
ODDS (%)
Bullish Trend 2 days ago
58%
Bearish Trend 2 days ago
67%
View a ticker or compare two or three
Interact to see
Advertisement
GMED
Daily Signal:
Gain/Loss:
LIVN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GCMCX27.620.15
+0.55%
Goldman Sachs Mid Cap Value C
FPURX26.75N/A
N/A
Fidelity Puritan
PXDIX10.75N/A
N/A
Impax Global Sustainable Infras Instl
PJSQX25.42-0.10
-0.39%
PGIM Jennison Small Company R6
VMNIX13.84-0.07
-0.50%
Vanguard Market Neutral I

GMED and

Correlation & Price change

A.I.dvisor indicates that over the last year, GMED has been closely correlated with SENS. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if GMED jumps, then SENS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GMED
1D Price
Change %
GMED100%
-0.45%
SENS - GMED
71%
Closely correlated
+1.40%
PAVM - GMED
68%
Closely correlated
+7.21%
AXGN - GMED
67%
Closely correlated
-2.81%
MOVE - GMED
66%
Loosely correlated
+4.87%
INBS - GMED
64%
Loosely correlated
-6.14%
More

LIVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LIVN has been loosely correlated with ENOV. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if LIVN jumps, then ENOV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIVN
1D Price
Change %
LIVN100%
-0.76%
ENOV - LIVN
51%
Loosely correlated
+4.68%
GMED - LIVN
50%
Loosely correlated
-0.45%
PEN - LIVN
49%
Loosely correlated
-4.52%
STE - LIVN
49%
Loosely correlated
+0.99%
CRL - LIVN
48%
Loosely correlated
+0.10%
More